泸州医学院学报
瀘州醫學院學報
로주의학원학보
JOURNAL OF LUZHOU MEDICAL COLLEGE
2013年
4期
376-378
,共3页
骨损伤%血栓%华法林
骨損傷%血栓%華法林
골손상%혈전%화법림
Bone trauma%Venous thromboembolism%Warfarin
目的:探讨抗凝药物华法林对骨损伤所致血栓的治疗是否有效和安全。方法:回顾性研究骨科病房20例经华法林治疗的深静脉血栓和/或肺动脉栓塞病人情况。结果:血栓的诊断在入院后平均13.5±3.4d被确诊。其中肺动脉血栓8例,深静脉栓塞12例,多普勒超声确诊11例,CT确诊有9例。抗凝治疗后约25 d,5例病人血栓完全消失,剩下15例的栓体大小有了明显减小,无并发症发生。结论:华法林治疗对于骨损伤病人所致深静脉和肺动脉血栓形成有较好的疗效,并能抑制并发症的产生。
目的:探討抗凝藥物華法林對骨損傷所緻血栓的治療是否有效和安全。方法:迴顧性研究骨科病房20例經華法林治療的深靜脈血栓和/或肺動脈栓塞病人情況。結果:血栓的診斷在入院後平均13.5±3.4d被確診。其中肺動脈血栓8例,深靜脈栓塞12例,多普勒超聲確診11例,CT確診有9例。抗凝治療後約25 d,5例病人血栓完全消失,剩下15例的栓體大小有瞭明顯減小,無併髮癥髮生。結論:華法林治療對于骨損傷病人所緻深靜脈和肺動脈血栓形成有較好的療效,併能抑製併髮癥的產生。
목적:탐토항응약물화법림대골손상소치혈전적치료시부유효화안전。방법:회고성연구골과병방20례경화법림치료적심정맥혈전화/혹폐동맥전새병인정황。결과:혈전적진단재입원후평균13.5±3.4d피학진。기중폐동맥혈전8례,심정맥전새12례,다보륵초성학진11례,CT학진유9례。항응치료후약25 d,5례병인혈전완전소실,잉하15례적전체대소유료명현감소,무병발증발생。결론:화법림치료대우골손상병인소치심정맥화폐동맥혈전형성유교호적료효,병능억제병발증적산생。
Objective: To study the therapeutic efficacy and safety of warfarin in patients with venous thromboembolism in bone trauma. Methods: 20 orthopedic patients with deep venous thromboembolism and/or pulmonary embolism treated with warfarin were retrospectively studied. Results: Thrombosis was diagnosed at an average of 13.5 ± 3.4 days after admission. Thrombus formation was confirmed in pulmonary arteries in 8 cases and in deep veins in 12 cases. Diagnosis was based on Doppler ultrasound findings in 11 cases and on computed tomography findings in 9 cases. Approximately 25 days after starting anticoagulant therapy, 5 thrombi disappeared and 15 thrombi reduced in size. Conclusions: Warfarin therapy clears deep vein and pulmonary artery thrombosis in bone trauma without any bleeding complications.